TOS announces FDA approval of new prescription drug for treating binge eating disorder

The United States Food and Drug Administration recently approved lisdexamfetamine dimesylate, under the brand name Vyvanse, to treat moderate to severe binge eating disorder (BED) in adults, a first of its kind prescription drug specifically indicated for BED.



from The Medical News http://ift.tt/1D8fdDs